association with DAF, but the converse constructs containing the first 10 amino acids of p60' plus the remainder of p56kk or p59'"' did not associate with DAF. Mutation of cysteine to serine at positions 3 and 6 in p59'" or positions 3 and 5 in p56k! abolished the association of these kinases with DAF. Mutation of serine to cysteine at positions 3 and 6 in p60"" conferred on p6(YFv the ability to associate with DAF. Direct labeling with [3H]palmitate demonstrated palmitylation of this amino-terminal cysteine motif in p56kk. Thus, palmitylation of the amino-terminal cysteine residue(s) together with myristylation of the amino-terminal glycine residue defines important motifs for the association of PTKs with GPI-anchored proteins.
T cells can be activated through a class of proteins that are bound to the outer leaflet of the cell membrane by a glycosyl-phosphatidylinositol (GPI) anchor (reviewed in ref- erence 14) . This has been demonstrated for a dozen members of this class, including murine Ly-6 (18), Thy-1 (8), Qa-2 (9), human decay-accelerating factor (DAF, CD55) (3), and CD59 (7, 12) . Cross-linking of the GPI-anchored proteins by antibodies leads to activation of T cells, as measured by an influx of extracellular calcium, production of interleukin-2, or cell proliferation. Signaling events through GPI-anchored proteins have also been observed in B cells, monocytes, and granulocytes (14) .
The GPI anchor is essential for this mode of T-cell activation, because transmembrane versions of the proteins cannot transduce signals (24, 30, 33) . In earlier studies, we expressed human DAF (15) , a 75-kDa protein that protects cells from complement-mediated damage (6, 16, 19) , both in its wild-type GPI-anchored form and as a transmembrane protein in the murine T-cell line EL-4. Only the GPIanchored form could signal, as measured by tyrosine phosphorylation and interleukin-2 production (30) . These findings raised a conceptual problem because the GPI-anchored proteins are inserted only in the outer leaflet of the lipid bilayer, so there is no clear mechanism for generating an intracellular signal. Two recent observations of Stefanova and colleagues (31, 32) shed light on the possible signal transduction pathway through GPI-anchored proteins. First, GPI-anchored proteins are associated with a transmembrane protein of 85 kDa in Triton X-100 cell lysates (31) , and this 6386 SHENOY-SCARIA ET AL.
MAb to Myc (9E10) (4) were purchased from Oncogene Sciences (Uniondale, N.Y.).
DNA constructs and mutagenesis. The p59fyl deletion mutants and the PTK chimeras were constructed essentially as described earlier (35) . The amino acid substitutions were introduced by polymerase chain reaction, using an oligonucleotide encoding the required mutation and plasmids encoding the respective wild-type forms of p59g', p561"", and p6Osrc as templates. DNA sequence analysis (27) Immunoprecipitations and immune complex kinase assay. Transfected HeLa cells were washed twice in cold phosphate-buffered saline and lysed in 0.5 ml of a lysis buffer containing 0.5% Triton X-100, 50 mM Tris (pH 7.6), 300 mM NaCl, 1 mM sodium orthovanadate, 5 mM EDTA, 10 pg of leupeptin per ml, 10 p,g of aprotinin per ml, 10 mM iodoacetamide, and 25 ,ug of p-nitrophenyl guanidinobenzoate per ml. The lysate was precleared with 10 ,u1 of normal rabbit serum per ml of lysate plus Pansorbin (Calbiochem, San Diego, Calif.) for 30 to 60 min at 4°C. Lysates were immunoprecipitated with appropriate antibodies, using Pansorbin as an immunoadsorbent as described earlier (17) . After three washes in 0.5% Triton X-100 buffer, the immunoprecipitate was resuspended in 50 ,ul of a solution containing 25 mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (HEPES; pH 7.4), 3 mM MnCl2, 100 ,uM sodium orthovanadate, and 10 ,uCi of [y-32P]ATP. The tubes were incubated for 15 min at room temperature. The immunoprecipitates were washed three times in the 0.5% Triton X-100 buffer containing 15 mM EDTA; the protein was eluted in 1 x reducing Laemmli buffer and analyzed on sodium dodecyl sulfate (SDS)-9% polyacrylamide gels.
For sequential immunoprecipitations, the kinase assay products from the first immunoprecipitation were eluted in 0.5% SDS in water at 70°C for 3 min. The eluate was diluted 10-fold with the 0.5% Triton X-100 buffer and subjected to a second round of immunoprecipitation essentially as described above.
Western blotting (immunoblotting). Ten percent of the cell lysates prepared for in vitro kinase assays was mixed with 3x Laemmli sample buffer, boiled, and run on SDS-9% polyacrylamide gels. Proteins were transferred from the gel to 0.45-p.m-pore-size nitrocellulose paper (Nitrobind; MSI), using the Bio-Rad transblot apparatus. Blots were developed essentially as described previously (36) . Briefly, the blot was blocked in Tris-buffered saline-0.05% Tween 20 (TBST) containing 3% nonfat dry milk for 1 The C32 cell line expresses the PTKs p60" and p59'3n as well as the GPI-anchored protein CD59. Cells were lysed in a buffer containing 0.5% Triton X-100, and CD59 was immunoprecipitated from these lysates and subjected to an in vitro kinase assay. CD59 was associated with phosphorylated proteins of 60 and 85 kDa (data not shown). To identify the kinase associated with CD59, we reimmunoprecipitated the initial CD59 immunoprecipitate with either anti-p60O"' or anti-p595'3n antibodies. Although the overall expression of p60' in the cell was greater than p59'3n, only p59'3n was associated with CD59 ( Fig. 1) .
We also examined human platelets, which express extremely high levels (0.3% of total protein) of p60"'. No association of p60O'" with either DAF or CDS9 could be detected, although the small amount of p59'3n expressed by platelets was associated with these GPI-anchored proteins (data not shown). (Fig. 2) . Little or no kinase activity associated with DAF was detected in cells transfected with src, although all the transfected cells had equivalent kinase activities (Fig. 2 ). This HeLa cell system has thus confirmed a specificity within the Src family of PTKs that we had demonstrated with lymphoid cells, C32 cell line, and platelets. The stoichiometries of this association were estimated by Western blot analysis using the HeLa cell line transfected with kck. An anti-p56lck Western blot of a DAF immunoprecipitate (compared with total cell lysate) demonstrated that -20% of p56C is associated with DAF (data not shown). The converse experiment with an anti-DAF Western blot of a p56t"" immunoprecipitate showed that -10% of DAF is associated with p56"'" in this cell line (data not shown). This HeLa cell expression system also allowed us to test altered forms of the PTKs to map the requirements for association with GPI-anchored proteins.
Nonmyristylated P17K does not associate with DAF. As all of the Src family of PTKs are myristylated, we first tested whether myristylation was required for the association of although it still possessed kinase activity (data not shown). Similarly, a nonmyristylated form of p596"' (Gly-2-Ala substitution) failed to associate with DAF (data not shown). Thus, amino-terminal myristylation is necessary for the association of p561ck and p59i"' with GPI-anchored proteins. However, as p6O"' is myristylated yet does not associate with GPI-anchored proteins, there must be additional determinants for this interaction.
Sequence of p590' required for DAF association. Since the Src family tyrosine kinases differ from each other primarily in the amino-terminal region, it was likely that sequences in the amino-terminal domains of p561Ck and p596"' directed the specific association with DAF. To examine this hypothesis, we used two p595"/p60' chimeras that had been generated previously (35) . One chimeric protein consisted of the amino-terminal 125 amino acids of p596"' joined to residues 125 to 533 of p6O"', and the other consisted of the aminoterminal 124 amino acids of p60 coupled to residues 126 to 534 of p59fy'. Expression of the p596"'(1-125)/p60" protein in HeLa cells followed by an in vitro kinase assay of the DAF immunoprecipitate demonstrated associated kinase activity (Fig. 4, lane 1) . In contrast, no associated kinase activity was detected in the DAF immunoprecipitates from HeLa cells expressing the p60(1-125)/p59VY' chimeric protein (Fig. 4, lane 2) . The two chimeric proteins expressed equivalent kinase activities, as assessed by an in vitro kinase assay of the p596"' or p6O' immunoprecipitates of transfected HeLa cells (Fig. 4, lanes 3 and 4) . Hence, the amino-terminal 125 amino acids of p596Y' mediated the specific association of p596'f with DAF.
The residues in the amino-terminal domain of p59fy' involved in the association with DAF were defined in greater detail by using deletion mutants. Since the p596"' antiserum recognizes regions within some of the deletions, the deletions were made in p596y' cDNA that had been tagged with an epitope (Myc) recognized by MAb 9E10. p596flv mutants with deletions at the amino terminus from 11 to 51 to 75, and 76 to 100 were expressed in HeLa cells, and associated kinase activity in DAF immunoprecipitates was examined. All four deletion mutants associated with DAF ( Fig. 5A ) and had equivalent levels of kinase activity (Fig.  SB) . Hence, our data indicated that although the aminoterminal 125 amino acids were crucial to the DAF-p595"' interaction, amino acid residues 11 to 100 of p59J5f were not critical. This finding focused attention on amino acid residues 1 to 10, but these amino acids could not be studied by this simple deletion analysis because they also contain the signal for the required N-terminal myristylation.
To investigate the role of the amino-terminal 10 amino acids, we used two chimeric proteins in which the first 10 amino acids of p595"' and p6Q" were interchanged. Both proteins were expressed in HeLa cells and tested for association with DAF by an in vitro kinase assay. Replacement of the first 10 amino acids of p59y'& with the first 10 amino acids of p60 abrogated the association of p59fy' with DAF (Fig. 6) . Alternately, the replacement of the first 10 amino acids of p60 with the corresponding residues of p595"' enabled this chimera to associate with DAF (Fig. 6 ). The two proteins had equivalent kinase activities, as assessed by an in vitro kinase assay of the p6OYrc and p59fy' immunoprecipitates (Fig. 6) . The 10 amino-terminal residues of p59V' are necessary and sufficient for its interaction with DAF.
The amino-terminal 10 residues of p56kk are critical in its interaction with DAF. To determine whether the 10 aminoterminal amino acids of p561ck also played a critical role in its association with DAF, we made analogous chimeric proteins between p561Ck and p60. The proteins were expressed in HeLa cells and examined for association with DAF by an in vitro kinase assay. Replacement of the 10 amino-terminal amino acids of p60 with the 10 amino-terminal amino acids of p561ck conferred on this p56lck/p6oS?C chimera the ability to associate with DAF (Fig. 7) . Conversely, replacing the first 2) . One-tenth of the total lysate was immunoprecipitated with either anti-p60" (MAb EC10) or anti-p59f" (rabbit antiserum), respectively, subjected to an in vitro kinase assay, and analyzed by SDS-PAGE and autoradiography (lanes 3 and 4).
10 amino acids of p56kC-with the first 10 amino acids of p6O0 abrogated the ability of the p6(frc/p56lck chimera to associate with DAF (Fig. 7) . The two chimeric proteins had equivalent kinase activities (Fig. 7) . Thus, the amino-terminal 10 amino acids of p561ck are critical to its association with DAF.
The two cysteines within the 10 amino-terminal amino acids of the PTK confer the ability to associate with DAF. Comparison of the sequences of the amino-terminal 10 amino acids of p60, p59OP, and p561Ck (Fig. 8) (Fig.   9A ). Thus, wild-type p56kk but not the p561Ck (Cys-3,5-*Ser) mutant associated with DAF (Fig. 9A) , although the overall expression of both the wild-type and mutant kinases was the same (Fig. 9B) . Similar results were obtained for wild-type Wild-type Ick andfrn transfectants served as controls. Immunoprecipitates were assayed for associated kinase activity and eluted in 0.5% SDS. After a 10-fold dilution with 0.5% Triton X-100, the material was reimmunoprecipitated with anti-p56'k (rabbit antiserum) or anti-p59'5" (rabbit antiserum), respectively, and analyzed by SDS-PAGE and autoradiography. (B) One-tenth of the total lysate was immunoprecipitated with anti-p561ck or anti-p59'5'n, assessed for kinase activity by the in vitro kinase assay, and analyzed by SDS-PAGE and autoradiography.
p595'5n and the p59'5n (Cys-3,6-.Ser) mutant (Fig. 9) . The cysteine-to-serine substitutions did not interfere with the myristylation signal, as both the wild-type p595'5n and the p59'ynCys-3,6 --Ser) mutant could be metabolically labeled with [ H]myristate (Fig. 10) ; no [3H]myristate was incorporated by the p59'3n (Gly-2--Ala) mutant (Fig. 10) , consistent with this glycine residue being a required part of the signal 11 . Mutation of the amino-terminal serine pair to cysteines in p60"C confers on p6O' the ability to associate with DAF. Cells transfected with either wild-type src or the src(Ser-3,6---Cys) mutant cDNA were lysed and immunoprecipitated with anti-DAF MAb 1H4. Untransfected cells (Mock) served as a control. The immunoprecipitate was assayed for associated kinase activity and analyzed by SDS-PAGE and autoradiography (lanes 1 to 3) . One-half of the kinase-treated immunoprecipitate was eluted in 0.5% SDS. After a 10-fold dilution with 0.5% Triton X-100, the material was reimmunoprecipitated with anti-p6W' (MAb 327) and analyzed by SDS-PAGE and autoradiography (lanes 3 to 6). One-tenth of the total lysate was immunoprecipitated with anti-p6G"r, subjected to an in vitro kinase assay, and analyzed by SDS-PAGE and autoradiography (lanes 7 to 9). for myristylation. Hence, our data clearly indicate that the cysteines present at positions 3 and 5/6 in p56kck and p5915f play a very critical role in the association of these kinases with DAF.
Since p60 did not have cysteines at these corresponding positions, we mutated the serines at positions 3 and 6 in p60 to cysteines. This mutant p60 protein was expressed in HeLa cells by using the recombinant vaccinia virus system and examined for association with DAF by an in vitro kinase assay. Wild-type p6OYrc was also expressed in HeLa cells as a control. Substitution of cysteines at positions 3 and 6 conferred the ability of this mutant p60' to associate with DAF (Fig. 11, lanes 1 to 3) . To confirm the association of the mutant p60 with DAF, we reimmunoprecipitated the initial kinase-treated DAF immunoprecipitate with anti-p6G" antibody (Fig. 11, lanes 4 to 6) . The wild-type p60 and the mutant p60 expressed equivalent kinase activities, as evidenced by an in vitro kinase assay on the p6fYrc immunoprecipitates (Fig. 11, lanes 7 to 9) . The two cysteines, therefore, define a critical sequence motif for the association of the PTK with the GPI-anchored protein.
Palmitylation of p56kk at the amino-terminal cysteine motif. Alternate models can be proposed to explain why the cysteine residues at the amino terminus of the PTK are important for the interaction with GPI-anchored proteins (see Discussion). Given a recent report of palmitylation of p56kck (21) , and since palmitylation occurs on cysteine residues, we considered a model in which lipid modification of the PTK affects its interaction with the GPI-anchored pro- (Fig. 12, lane 1) , confirming the palmitylation of p5610k (21) . Mutation of the amino-terminal cysteine motif, which blocks association of the PTK with GPI-anchored proteins (Fig. 9) , completely abrogated palmitate incorporation (Fig. 12, lane 2) . Thus, palmitylation of the PTK occurs on one or both of the amino-terminal cysteine residues, and this modification, along with amino-terminal myristylation of glycine, is critical for the association of the PTK with GPI-anchored proteins.
DISCUSSION
The class of GPI-anchored membrane proteins has gone from representing a minor, unusual structural feature to being recognized as a major group of membrane proteins (14) . Along with this structural assessment has come the search for common functions of the GPI structure. One such function is a role in cell activation or signaling. Initially it was observed that several GPI-anchored proteins could signal in T cells: cross-linking of the GPI-anchored protein with antibody (presumably playing the role of ligand) led to proliferation in human or mouse T cells. At least a dozen GPI-anchored proteins could function in this regard, and studies with chimeric proteins with alternative forms of membrane anchoring (GPI versus transmembrane) established that the GPI anchor was essential to T-cell activation (24, 30, 33) .
Since the GPI-anchored protein does not traverse the cell membrane, it is not readily apparent how intracellular signals are generated from these molecules. Initially it was proposed that signal transduction mechanisms either derived directly from the GPI-anchored protein, e.g., through cleavage to yield diacylglycerol as a second messenger, or were based on the association of one or more signal-transducing molecules with the GPI-anchored protein (23) . The demonstration that the PTKs p56 ck (30, 32) and p59fy' (30, 34) were noncovalently associated with DAF, Thy-1, and other GPIanchored proteins provided potential evidence for the latter hypothesis. However, the model is still incomplete because the PTKs are inserted in the inner leaflet of the plasma membrane through an amino-terminal myristate and the GPI-anchored proteins are inserted in the outer leaflet of the plasma membrane through the carboxyl-terminal phosphatidylinositol. Thus, it is likely that a third component of the signaling complex connects the GPI-anchored protein and the PTK, and a candidate molecule of 85 kDa has been identified in the GPI anchorlPTK complex (31) . This model bears an analogy to signaling through the T-cell receptor/ CD3 complex in which tyrosine phosphorylation by a nonreceptor PTK is an early and required event (10, 11, 20) .
In this study, we addressed the question of the specificity of the PTK that associates with GPI-anchored membrane proteins. Previously we demonstrated that DAF associated with the PTKs p56 ck and p59&fy (30) . Here we have shown that p6O'" did not associate with DAF under the same conditions. This finding of specificity lends additional confirmation to the existence of the GPI anchor/PTK complex, ruling out the possibility of general but nonspecific binding, perhaps based on the amino-terminal myristate or some other general structural property of all Src family PTKs.
The identification of specificity among the Src family PTKs in the association with GPI-anchored proteins permitted an approach to mapping the domain and sequences responsible for this interaction. Chimeras between p59f5vf and p60 demonstrated that the 125 amino-terminal amino acids were responsible for the complex (Fig. 4) , and deletion analysis of p59SKY narrowed this region to the amino-terminal 10 residues (Fig. 5) . This finding was directly confirmed with chimeras in which the 10 amino-terminal residues of p59'-" (Fig. 6) or pS6kk (Fig. 7) were switched with those of p60.
Many of these mutations and chimeras had been generated (35) to study the association of p596fy with the zeta chain of the T-cell receptor complex (26) . The amino-terminal domain of p59nfy directs association with both DAF and the zeta chain (35) . However, the actual binding motif within the amino terminus of p59fy? must differ in these two cases, as the amino terminus of p56Ick also directed association with DAF ( Fig. 7) yet p56lck did not associate with the zeta chain (35) .
The 10 amino acids at the amino terminus of p59nfy and p561k having been identified as containing a signal for association with GPI-anchored proteins, the search for specific sequence motifs Within that domain was guided by alignment of the sequences (Fig. 8) . Most notable was the presence of two cysteine residues in p59Yfy and p561ck but not in p60, which contained serine residues at these positions. Switching between the cysteine and serine residues showed that the cysteines were necessary (Fig. 9) and sufficient ( Fig.  11) within the overall context of a Src family PTK to lead to association of the PTK with the GPI-anchored proteins. How this cysteine motif at the amino terminus leads to the association was not immediately apparent. The association does require amino-terminal myristylation of the PTK, as a nonmyristylated version of p59fy' or pS6lck does not associate. This is not sufficient for the association, however, as p60 is also myristylated yet does not associate with GPI-anchored proteins unless the appropriate cysteine residues are substituted. One model would be a complex of the GPI-anchored protein, a transmembrane signal transduction molecule (perhaps the 85-kDa molecule), and the appropriate PTK. The transmembrane component would have affinity for both other molecules, with the amino-terminal cysteine motif serving as part of the binding site on the PTK. However, the only conserved residues in the amino terminus of those PTKs that associate with GPI-anchored proteins, i.e., pS6"k, p59*5f, and the p6O'(Ser-3,6--+Cys) mutant, are the amino-terminal glycine and the cysteines, and it seems somewhat unlikely that these residues alone would form a complete peptide binding site.
An alternative model involves a posttranslational modification of the cysteine residues creating a structural change of the PTK that is necessary for association with the GPIanchored proteins. This association is not based on disulfide bonds, as we observed the same complex of GPI-anchored proteins and PTKs when analysis was done under reducing or nonreducing conditions (data not shown). The most likely posttranslational modification of these cysteine residues of the PTK is palmitylation via a thioester linkage. Indeed, a recent report provided evidence for palmitylation of p56kk, although the site of palmitylation was not identified (21) . Our data confirm that finding and establish specifically that the amino-terminal cysteine residues of the PTK are the sites of palmitylation. Replacement of these cysteine residues abrogates both the palmitylation of the PTK and its association with the GPI-anchored membrane proteins. The GPI-anchored membrane proteins are enriched in lipid subdomains of the membrane (1); it is thus possible that the palmitylation of the amino-terminal cysteine residue(s) of the PTK together with myristylation of the amino-terminal glycine residue is needed to localize the PTK to these same lipid subdomains. In agreement with this model, we found that p59Of and p56lck but not p6Q' are contained in these lipid subdomains (3a) .
It should be noted that the involvement of cysteines at positions 3 and 5 of p56lck in the association with GPIanchored proteins must be distinguished from the involvement of cysteines at positions 20 and 23 of p56lck (29, 37) in the association with CD4 and CD8 (25, 38) . The association of CD4 and CD8 with p561ck is critically dependent on the presence of free cysteine residues presumably involved in a metal ion coordination complex (29) . The p56lck-CD4 or -CD8 interaction is destroyed by the alkylating agent iodoacetamide, which blocks free cysteine residues, and by the metal ion-chelating agent 1,10-orthophenanthroline (29) , whereas the GPI anchor-p56kck interaction is stable to both of these treatments (32) . The work presented in this report has partially defined the molecular basis for the association of selected members of the Src family of PTKs with GPI-anchored membrane proteins. Further understanding will require identification of the additional molecules and membrane structures that underlie the GPI anchor/PTK complex.
